REHANA LATIF: Open Payments
NPI 1184638140 · BRONXVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 34 payments from 7 companies in 2025. Trend: 2023 $1,527 · 2024 $883 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $199 |
| Vanda Pharmaceuticals Inc. | 8 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $126 |
| Alkermes, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Lundbeck LLC | 2 | $57 |
Products named: VRAYLAR, REXULTI, CAPLYTA, ARISTADA, HETLIOZ, TRINTELLIX, FANAPT.
Industry payments across NY — which companies pay providers there.
